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Areas endemic of helminth infection, tuberculosis (TB) and HIV are to a large extent 
overlapping. The aim of this study was to assess the impact of asymptomatic helminth infection 
on the immunological response among TB patients with and without HIV, their house hold 
contacts and community controls. 
Methodology 
Consecutive smear positive TB patients (n = 112), their household contacts (n = 71) and 
community controls (n = 112) were recruited in Gondar town, Ethiopia. Stool microscopy, HIV 
serology, serum IgE level, eosinophil and CD4 counts were performed and tuberculosis patients 
were followed up for 3 months after initiation of anti-TB treatment. 
Results 
Helminth co-infection rate was 29% in TB patients and 21% in both community control and 
household contacts (p = 0.3) where Ascaris lumbricoides was the most prevalent parasite. In TB 
patients the seroprevalence of HIV was 47% (53/112). Eosinophilia and elevated IgE level were 
significantly associated with asymptomatic helminth infection. During TB treatment, the worm 
infection rate of HIV+/TB patients declined from 31% (10/32) at week 0 to 9% (3/32) at week 2 
of TB treatment, whereas HIV−/TB patients showed no change from baseline to week 2, 29% 
(13/45) vs. 22.2% (10/45). This trend was stable at week 8 and 12 as well. 
Conclusion 
One third of smear positive TB patients were infected with helminths. Eosinophilia and elevated 
IgE level correlated with asymptomatic worm infection, indicating an effect on host immunity. 
The rate of worm infection declined during TB treatment in HIV+/TB co-infected patients 
whereas no decline was seen in HIV−/TB group. 
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Introduction 
Infections caused by intestinal helminths are associated to divergent animal groups and are 
highly prevalent worldwide, affecting populations living in poor regions [1]. Intestinal helminths 
are reported to induce a Th-2 type immunity in the host [2] and evidence suggests that the Th2 
immune response may play a crucial role in reducing the severity of acute disease upon helminth 
infection [3]. The immune response of the host to worm infection correlates with the production 
of interleukin 4 (IL-4), IL -5, IL-9, IL-10, and IL-13 and consequently the development of strong 
Immunoglobulin E (IgE) and eosinophilia [3]. 
Studies have indicated that the humoral immune response to parasites favours infection 
by Mycobacterium tuberculosis and that helminth infected individuals could be at risk for 
developing tuberculosis (TB) [4]. A case control study conducted in Ethiopia has shown that the 
prevalence of worms in active TB patients was higher than in their healthy household 
contacts [5]. This observation is supported by other studies conducted in different areas [4], [6]. 
The association between eosinophilia and protective immunity in human subjects came from the 
post-treatment, re-infection studies in schistosomiasis that demonstrated a direct relationship 
between the lack of re-infection and the level of peripheral blood eosinophils [7]–[8]. It was 
furthermore shown that up-regulation of Th2 responses including eosinophilia and IgE hyper 
responsiveness [9] by helminthic infection can suppress the production of a Th1 immune 
response which is important to combat intracellular pathogens such as M. Tuberculosis[5], [10]–
[11]. Previous reports have also indicated that regulatory T cells are expanded in patients with 
TB and may contribute to suppression of Th1-type immune responses [12]. In this study, we 
assessed the magnitude of worm infection in TB patients in Gondar town compared to household 
contacts and community controls and investigated the relation of surrogate markers to Th2 type 
immune response at TB diagnosis, and the rate of helminth infection during follow up after TB 
treatment in relation to levels in household contacts and community controls. 
Materials and Methods 
Patients 
Consecutive newly diagnosed smear positive tuberculosis patients between the ages of 15–65 
years were recruited at the Directly Observed Treatment Short-course (DOTS) clinic at 
University of Gondar Hospital (GUH) and Gondar Health Centre, Ethiopia. Smear positive TB 
was defined as at least two sputum smears positive for acid fast bacilli (AFB) or one smear 
positive slide and x-ray results suggestive of TB. All individuals, irrespective of age, who lived 
together with TB patients in the same house and had no previous TB history or any evidence of 
TB on chest x-ray were recruited as house hold contacts (HC). Apparently healthy blood donors 
who visited the blood bank at the GUH during the study period, and had passed pre-donation 
clinical screening to rule out any chronic illnesses and previous TB history, were enrolled as 
community controls (CC). Hospitalized patients, pregnant women and those with concomitant 
disease other than HIV were excluded from participation. TB patients were followed up after 
enrolment at weeks 2, 8 and 12. None of the study participants had symptoms suggestive of 
helminth infection during enrolment or follow up. As per the HIV treatment programme in 
Ethiopia, HIV positive patients were put on anti- retroviral treatment and/or cotrimoxazole 
prophylactic treatment based on the working national guideline taking the WHO HIV clinical 
stage and CD4 count into account. 
HIV serology and CD4 count 
HIV screening was determined from whole blood samples using rapid HIV kits, Determine 
[(Determine® HIV-1/2 Ag/Ab Combo, US), Capillus (Trinity Biotech, US) and Unigold (Trinity 
Biotech, US)]. As per the national HIV testing algorithm, samples negative by Determine were 
reported as negative. But if the test became positive, the second test, Capillus, was done. The 
HIV result was then reported according to the results of Capillus test. i.e If the result of Capillus 
became concordant with Determine (positive test), the result was reported as positive. But for 
any discordant result of Determine and Capillus, the third test, Unigold, was used as tie breaker 
and the final result was decided based on the results obtained from Unigold test. 
CD4 count was performed using FacsScan machine (BD, USA) in 4 ml venous blood samples 
according to the manufactures' instructions. 
Assessment of helminth infection and surrogate markers for Th2 type 
immune response 
Three stool samples were collected using a strategy where one sample was collected daily for 
three consecutive days from each participant and then examined both using direct and Kato-Katz 
technique [13] by the same technician throughout the study. The results of positive or negative 
were based on the examination of all three samples together from each patient. One in 10 slides 
were randomly selected and checked again blindly by a second microscopist for quality control. 
Serum IgE was determined with a commercial ELISA kit (Immundiagnostik, Germany) 
according to the manufacturer's instruction. The absolute eosinophil count of peripheral blood 
was computed in mm3 from the value of total and differential white blood cell counts obtained 
using Cell Dyn 1800 (Abbot, USA). 
Ethical statement 
Written informed consent was obtained from all study participants. Written consent was obtained 
from the respective guardians for children below the age of 18. The study was approved by the 
Ethical Review Board of the University of Gondar, Ethiopia and by the Regional Ethics Review 
Board, Linköping, Sweden. 
Data analysis 
Data are presented in tables as median and inter quartile range. A p-value of <0.05 was 
considered as statistically significant. Significance testing was done with Mann Whitney and 
Wilcoxon tests for continuous data and Fisher's exact test for discrete variables. Variables with a 
p<0.1 in the univariate analysis were entered into a multiple regression analysis with helminth 
status as the dependent variable. The regression analysis was performed using the Statistica 
software (Tusla, USA). For the remaining statistical analysis Epinfo 2005 (version 3.5.1) was 
used. 
Results 
Baseline clinical data 
A total of 295 study participants were included in the study. Of these, 112 were TB patients, 112 
community controls (CC) and the remaining 71 were household contacts (HC) with median age 
of 28, 30 and 20 respectively (Table 1). A significantly higher HIV co-infection rate was 
identified among TB patients (47%) compared to CC (1.8%, p<0.001) and HC (11.6%, p<0.01). 
Within the TB group women were more commonly co-infected with HIV than men (58% vs 
36%, p = 0.016). Intestinal helminths were identified from 29% (32/112) of the TB patients, 21% 
(23/112) of the community controls and 21% (15/71) of the house hold contact
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Table 1. Comparison of immunological characteristics among participants in TB patients, 









Table 2. Intestinal helminths identified among study participants included in TB patients, 
community controls and house hold contacts.
https://doi.org/10.1371/journal.pone.0042901.t002
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Table 3. Immunological characteristics with respect to helminth status among participants in the 
TB, community control and household contact groups. 
https://doi.org/10.1371/journal.pone.0042901.t003 
Impact of asymptomatic co-infection on eosinophilia and IgE levels 
Eosinophilia (>300 cells/mm3) was correlated with helminth infection in TB group (p = 0.028) 
and community controls (p = 0.02). Similarly, elevated IgE (>120 IU/L) correlated with helminth 
infection in TB patients (p = 0.033), community controls (p = 0.01) and house hold contacts 
(p = 0.0008), (Table 3). In a multivariate regression analysis in the TB patients, eosinophilia 
(>500 cells/mm3; adjusted OR: 15.2; 95% CI: 1.4–160.3, p = 0.02) and increased IgE-levels 
(>120 kU/L, adjusted OR: 7.6; 95% CI: 1.2–48.4. p = 0.03) were independently associated with 
asymptomatic helminth infection, which was not confounded by sex or HIV-serostatus. TB 
patients co-infected with helminths had lower median eosinophil counts compared to community 
controls (234 cells/mm3 vs 600 cells/mm3, p<0.001) and household contacts (234 cells/mm3 vs. 
602 cells/mm3, p = 0.005) (Table 1). Similarly, helminth co-infected TB patients had lower 
median IgE levels at base line compared to community controls (351 IU/L vs. 378 IU/L, 
p<0.001) and house hold contacts (351 IU/L vs. 420 IU/L, p<0.001) infected with helminths 
(Table 1). 
Reduction in the rate of helminth infection in HIV coinfected patients 
following initiation of treatment against tuberculosis 
We observed a rapid decline in worm burden of HIV+/TB patients after 2, 8 and 12 weeks of TB 
treatment. The worm infection rate of HIV+/TB patients declined rapidly from 31% (10/32) at 
week 0 to 9% (3/32) at week 2, whereas HIV−/TB patients showed no change, with 29% (13/45) 
at week 0 and 22% (10/45) at week 2. This trend was stable at week 8 and after 3 months (Figure 
1). Of the total 77 TB patients for whom we had all follow up stool results, 86% [91% (29/32) of 
HIV positive and 82% (37/45) of HIV negative] had the same positive or negative worm status 









Figure 1. Trends of helminth status of HIV positive and HIV negative patients during TB treatment. 
https://doi.org/10.1371/journal.pone.0042901.g001 
Discussion 
Of the total 295 study participants included in the three groups, 24% were positive for intestinal 
parasites without any clinical symptoms suggestive of active infection. The co-infection rate of 
helminths among TB patients in the present study is similar with a report from Brazil [14]. 
Although still controversial, some studies suggested that the humoral immune response to 
parasites favours infection by Mycobacterium tuberculosis and thus the immune response to 
intestinal parasites could be a risk factor for developing tuberculosis [4]. This has been supported 
in studies conducted in different areas showing high association of helminth infection among TB 
patients, however the causality could not be definitely confirmed [4], [6]. In this study, we 
present further support for the hypothesis that even asymptomatic helminth infection affect the 
immune system as both eosinophilia (>300 cells/mm3) and increased IgE levels (120 KU/L) were 
found in the helminth infected groups of TB patients, community controls and house hold 
contacts. The TB co-infection rate with intestinal parasites in this study (29%) was less than the 
72% and 41% rates reported in the same hospital in 2006 and 2007 respectively [15]–[16]. 
Difference in patient selection is a probable explanation for the observed variation since only 
smear positive TB patients with symptoms suggestive to intestinal helminths were recruited in 
the study by Elias et al (Daniel Elias, personal communication). In addition, the two studies were 
conducted during the pre-HIV treatment era and then the start of anti- retroviral therapy (ART) 
and better care for HIV and TB/HIV patients might have changed the epidemiology. 
More than 30 thousands rural health extension workers were trained and currently have been 
working at community level all over Ethiopia [17]. The major task of this large pool is 
implementing different preventive health packages including development of latrines and 
improving hygienic practice at family level which may have direct impact in reducing helminth 
infection. Thus, the contribution of increasing awareness and improving hygienic practice could 
have had an impact on an actual decrease in the magnitude of intestinal parasites in the 
area. Ascaris lumbricoides was the prevailing intestinal parasite species identified in the three 
categories with varying proportions (range from 33% to 61%). In contrast to earlier studies 
conducted in the area, we found a higher hook worm rate (range from 25% to 52%) observed in 
the three groups. 
Results from human and animal models have shown that eosinophilia and elevated IgE are one 
effector mechanism of immunity during parasite invasion [18]. Setting of cut off value for 
eosinophilia using the adopted reference range may not be appropriate for Ethiopian population 
since previous reports indicated that the hematological reference range of healthy Ethiopians was 
lower than the adopted reference range [19]. Thus, we used two cut off values to determine 
eosinophilia (>300 cell/mm3, applicable to Ethiopian population and >500 cells/mm3 which is 
the commonly used cut off). Accordingly, using cut off value of >300 cells/mm3, eosinophilia 
was associated with helminth status in the TB group (p = 0.028) and community controls 
(p = 0.02) but this statistical association was lost at the cut off value of >500 cells/mm3 (p = 0.05 
and p = 0.07, respectively). However, increased IgE level was associated with worm infection in 
TB patients (p = 0.033), community controls (p = 0.01) and house hold contacts (p = 0.008). Thus, 
our study confirms the hypothesis that asymptomatic helminth infection correlates to effects on 
host immunity illustrated by increased eosinophil counts and IgE levels. 
To our knowledge, no previous reports have followed helminth infection status during anti-TB 
treatment. There was no on-going routine screening for helminth infection in the area and all 
patients were asymptomatic and had not received anti-helminthic treatment during the 12 week 
follow up period. During the study period, participants were closely followed. We observed a 
rapid and marked decline in worm burden of HIV+/TB patients followed at 2, 8 and 12 weeks 
after anti-TB treatment. This was supported by the observation that among the 77 TB patients 
included in the analysis, most of the helminth positive patients, 86% (66/77) had same worm 
status in accordance to week 0 stool results throughout the follow up at week 2, week 8 and 
month 3. 
Even though the HAART (Highly Active Anti-Retroviral Therapy) -induced reconstitution of 
cellular immunity would be the main factor for reducing opportunistic infections among HIV 
patients, in vitro and in vivo investigations indicated that HIV treatment, especially with protease 
inhibitors (PIs), could have a direct effect in killing of parasites including malaria [20]–[21]. In 
addition, an anti-helminthic effect of cotrimoxazole (used as prophylaxis in HIV positives) 
cannot be excluded, similar to its described anti-malarial effect [22]. Thus, the antiretroviral 
therapy and effect of cotrimoxazole might have contributed to the rapid decline in worm rate 
seen in our study without direct anti-helminthic therapy. This requires further studies including 
more subjects and information on exact ART regimen and co-trimoxazole prophylaxis and the 
lack of such information is a clear limitation of our study which was not design to explore this 
difference. 
In summary, a high burden of intestinal parasites was observed among TB patient and 
asymptomatic helminth infection correlated to increased eosinophil count and serum IgE levels 
indicating an effect on host immunity. Additionally, we noted a rapid decline in the rate of worm 
infection among HIV+/TB co-infected patients, without direct anti-helminthic treatment, after 2 
weeks of TB treatment. 
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